Cas:874290-97-8 N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine-4-carboxamide manufacturer & supplier

We serve Chemical Name:N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine-4-carboxamide CAS:874290-97-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine-4-carboxamide

Chemical Name:N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine-4-carboxamide
CAS.NO:874290-97-8
Synonyms:4-Morpholinecarboxamide, N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-;N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-carboxamide;N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-morpholinecarboxamide
Molecular Formula:C17H25BN2O4
Molecular Weight:332.202
HS Code:2934999090

Physical and Chemical Properties:
Melting point:248-250ºC
Boiling point:518.8±50.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.545
PSA:60.03000
Exact Mass:332.190735
LogP:1.86080

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Morpholinecarboxamide, N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-morpholinecarboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-morpholinecarboxamide Use and application,N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-carboxamide technical grade,usp/ep/jp grade.


Related News: Findings show that there is a decline in the body’s immunity over time. The aim of the supplementary dose is to build it up again, and thus reduce the chances of infection and serious illness significantly,” Bennett told a news conference.
“I call on all the seniors who received the second dose, go get the supplementary one,” he said. “My first telephone call, after I finish speaking, will be to the person dearest to me, my mother, so that I can take her to be vaccinated immediately. Methanesulfonic acid 3-fluoromethyl-benzyl ester manufacturers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 4-chloro-6-[3-(6-methyl-pyridyn-2-yl)-isoxazol-4-yl]-quinoline suppliers Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. 3-(bis(phenylthio)methyl)cyclohexanone vendor & factory.